236 related articles for article (PubMed ID: 30443169)
1. Influence of DNA methylation on the expression of OPG/RANKL in primary osteoporosis.
Wang P; Cao Y; Zhan D; Wang D; Wang B; Liu Y; Li G; He W; Wang H; Xu L
Int J Med Sci; 2018; 15(13):1480-1485. PubMed ID: 30443169
[No Abstract] [Full Text] [Related]
2. Role of DNA methylation in the regulation of the RANKL-OPG system in human bone.
Delgado-Calle J; Sañudo C; Fernández AF; García-Renedo R; Fraga MF; Riancho JA
Epigenetics; 2012 Jan; 7(1):83-91. PubMed ID: 22207352
[TBL] [Abstract][Full Text] [Related]
3. Expression of Sclerostin in Osteoporotic Fracture Patients Is Associated with DNA Methylation in the CpG Island of the
Cao Y; Wang B; Wang D; Zhan D; Mai C; Wang P; Wei Q; Liu Y; Wang H; He W; Xu L
Int J Genomics; 2019; 2019():7076513. PubMed ID: 30729116
[TBL] [Abstract][Full Text] [Related]
4. OPG/RANKL/RANK gene methylation among alcohol-induced femoral head necrosis in northern Chinese men.
Wang T; Wang F; Liu T; Sun M; An F; Liu C; Tian Y; Cao Y; Wang J
J Orthop Surg Res; 2021 Mar; 16(1):223. PubMed ID: 33773583
[TBL] [Abstract][Full Text] [Related]
5. RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus.
Bonfá AC; Seguro LP; Caparbo V; Bonfá E; Pereira RM
Osteoporos Int; 2015 May; 26(5):1563-71. PubMed ID: 25609157
[TBL] [Abstract][Full Text] [Related]
6. Development of a High-Throughput Screening Strategy for Upregulators of the OPG/RANKL Ratio with the Potential for Antiosteoporosis Effects.
Gong S; Han X; Li X; Yang J; He X; Si S
J Biomol Screen; 2016 Aug; 21(7):738-48. PubMed ID: 27301430
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation in the OPG/RANK/RANKL pathway is associated with steroid-induced osteonecrosis of the femoral head.
Sun M; Cao Y; Yang X; An F; Wu H; Wang J
BMC Musculoskelet Disord; 2021 Jun; 22(1):599. PubMed ID: 34187427
[TBL] [Abstract][Full Text] [Related]
8. [Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head].
Wang J; Wang K; Shi Z; Zhang M
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Oct; 22(10):1161-4. PubMed ID: 18979868
[TBL] [Abstract][Full Text] [Related]
9. RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis.
Giner M; Rios MA; Montoya MA; Vázquez MA; Naji L; Pérez-Cano R
J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):46-51. PubMed ID: 19073256
[TBL] [Abstract][Full Text] [Related]
10. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis.
Samara S; Dailiana Z; Chassanidis C; Koromila T; Papatheodorou L; Malizos KN; Kollia P
Exp Mol Pathol; 2014 Feb; 96(1):9-14. PubMed ID: 24200492
[TBL] [Abstract][Full Text] [Related]
11. Effect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts.
Jurado S; Garcia-Giralt N; Díez-Pérez A; Esbrit P; Yoskovitz G; Agueda L; Urreizti R; Pérez-Edo L; Saló G; Mellibovsky L; Balcells S; Grinberg D; Nogués X
J Cell Biochem; 2010 May; 110(2):304-10. PubMed ID: 20225238
[TBL] [Abstract][Full Text] [Related]
12. 5-Aza-2-deoxycytidine inhibits osteolysis induced by titanium particles by regulating RANKL/OPG ratio.
Wang Y; Liu H; Wu J; Liao Y; Lu D; Dong F; Li H; Zhang Z; Lian Y
Biochem Biophys Res Commun; 2020 Aug; 529(3):629-634. PubMed ID: 32736684
[TBL] [Abstract][Full Text] [Related]
13. Isomeric flavonoid aglycones derived from Epimedii Folium exerted different intensities in anti-osteoporosis through OPG/RANKL protein targets.
Jiang J; Xiao S; Xu X; Ma H; Feng C; Jia X
Int Immunopharmacol; 2018 Sep; 62():277-286. PubMed ID: 30036771
[TBL] [Abstract][Full Text] [Related]
14. [Expression of receptor activator of NF-κB ligand and osteoprotegerin in peri-implant tissues during unloading period].
Zhou WJ; Liu ZH; Hao PJ; Xu S; Sun AJ; Li ZR
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 May; 47(5):310-3. PubMed ID: 22883830
[TBL] [Abstract][Full Text] [Related]
15. Opg/Rankl mRNA dynamic expression in the bone tissue of ovariectomized rats with osteoporosis.
Li CW; Liang B; Shi XL; Wang H
Genet Mol Res; 2015 Aug; 14(3):9215-24. PubMed ID: 26345854
[TBL] [Abstract][Full Text] [Related]
16. Changes of serum soluble receptor activator for nuclear factor-κB ligand after glucocorticoid therapy reflect regulation of its expression by osteoblasts.
Kaneko K; Kusunoki N; Hasunuma T; Kawai S
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1909-17. PubMed ID: 22791764
[TBL] [Abstract][Full Text] [Related]
17. The role of CD40 and CD40L in bone mineral density and in osteoporosis risk: A genetic and functional study.
Panach L; Pineda B; Mifsut D; Tarín JJ; Cano A; García-Pérez MÁ
Bone; 2016 Feb; 83():94-103. PubMed ID: 26545336
[TBL] [Abstract][Full Text] [Related]
18. Allelic variations of RANKL/OPG signaling system are related to bone mineral density and in vivo gene expression.
Takács I; Lazáry A; Kósa JP; Kiss J; Balla B; Nagy Z; Bácsi K; Speer G; Lakatos P
Eur J Endocrinol; 2010 Feb; 162(2):423-31. PubMed ID: 19934266
[TBL] [Abstract][Full Text] [Related]
19. The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio.
Rauner M; Stupphann D; Haas M; Fert I; Glatigny S; Sipos W; Breban M; Pietschmann P
J Rheumatol; 2009 Jan; 36(1):120-6. PubMed ID: 19040304
[TBL] [Abstract][Full Text] [Related]
20. Expression of RANKL/OPG during bone remodeling in vivo.
Tanaka H; Mine T; Ogasa H; Taguchi T; Liang CT
Biochem Biophys Res Commun; 2011 Aug; 411(4):690-4. PubMed ID: 21771583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
